Amini Yousef, Tebianian Majid, Mosavari Nader, Fasihi Ramandi Mahdi, Ebrahimi Seyyd Mahmoud, Najminejad Hamid, Dabaghian Mehran, Abdollahpour Meghdad
a Microbiology & Virology Research Center, Bu-Ali Research Institute, Mashhad University of Medical Sciences , Mashhad , Iran.
b Razi Vaccine and Serum Institute , Karaj , Iran.
Artif Cells Nanomed Biotechnol. 2017 Mar;45(2):291-296. doi: 10.3109/21691401.2016.1146735. Epub 2016 Feb 28.
Introduction The early secreted antigenic target 6-kDa protein (ESAT-6) plays an important role in immune protection against Tuberculosis. Owing to its great potential to increase immune response, chitosan can be considered as a suitable biodegradable polymer for intranasal administration. Methods The physiochemical properties of the nanoparticle were measured in vitro. Two weeks after the last intranasal administration, blood samples were collected and specific IgG, IFN-gama, and IL-4 levels were measured by ELISA. Results Chitosan nanoparticles containing ESAT-6 demonstrated stronger ability to induce IFN-gama, IL-4, and IgG antibody level than the control groups. Conclusion Administration of chitosan nanoparticles can be a suitable method to induce more appropriate immune responses against low inherent immunogenic tuberculosis proteins through intranasal routs.
引言 早期分泌抗原靶6 kDa蛋白(ESAT-6)在抗结核免疫保护中起重要作用。由于壳聚糖具有增强免疫反应的巨大潜力,它可被视为一种适合用于鼻内给药的可生物降解聚合物。方法 在体外测量纳米颗粒的理化性质。末次鼻内给药两周后,采集血样,通过酶联免疫吸附测定法(ELISA)测量特异性IgG、干扰素-γ(IFN-γ)和白细胞介素-4(IL-4)水平。结果 含ESAT-6的壳聚糖纳米颗粒比对照组表现出更强的诱导IFN-γ、IL-4和IgG抗体水平的能力。结论 通过鼻内途径给予壳聚糖纳米颗粒可能是一种合适的方法,可针对低固有免疫原性的结核蛋白诱导更适当的免疫反应。